Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Implications of noncoding regulatory functions in the development of insulinomas

  • Ramos-Rodríguez, Mireia
  • Subirana-Granés, Marc
  • Norris, Richard
  • Fernández Ruiz, Ángel
  • Fuentes Páez, Georgina
  • Pérez-González, Beatriz
  • Berenguer Balaguer, Clara
  • Raurell Vila, Helena
  • López Bigas, Núria
  • González-Pérez, Abel
  • Pasquali, Lorenzo
Insulinomas are rare neuroendocrine tumors arising from pancreatic β cells, characterized by aberrant proliferation and altered insulin secretion, leading to glucose homeostasis failure. With the aim of uncovering the role of noncoding regulatory regions and their aberrations in the development of these tumors, we coupled epigenetic and transcriptome profiling with whole-genome sequencing. As a result, we unraveled somatic mutations associated with changes in regulatory functions. Critically, these regions impact insulin secretion, tumor development, and epigenetic modifying genes, including polycomb complex components. Chromatin remodeling is apparent in insulinoma-selective domains shared across patients, containing a specific set of regulatory sequences dominated by the SOX17 binding motif. Moreover, many of these regions are H3K27me3 repressed in β cells, suggesting that tumoral transition involves derepression of polycomb-targeted domains. Our work provides a compendium of aberrant cis-regulatory elements affecting the function and fate of β cells in their progression to insulinomas and a framework to identify coding and noncoding driver mutations., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2017-86242-R and PID2020-117099RB-I00) “Unidad de Excelencia Maria de Maeztu” (CEX2018-000792-M). M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award. MARBiobanc’s work was supported by grants from Instituto de Salud Carlos III/FEDER (PT20/00023) and the “Xarxa de Bancs de tumors” sponsored by Pla Director d'Oncologia de Catalunya (XBTC). The islet isolation has been funded by grants PI19/00246 and PI22/00334 to E.M. from Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund (ERCF).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel Luis
  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Pasquali, Lorenzo
  • Eizirik, Décio L.
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells., This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS), Welbio CR-2015A-06 and CR-2019C-04, Belgium; the Horizon 2020 Program, T2Dsystems (GA667191); the National Institutes of Health, NIH-NIDDK-HIRN Consortium 1UC4DK104166-01 and Innovate2CureType1 - Dutch Diabetes Research Fundation (DDRF). D.L.E. and P.M. have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No. 115797 (INNODIA). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”. The DiViD study is funded by The South-Eastern Norway Regional Health Authority (grant to K.D.-J.), the Novo Nordisk Foundation (grant to K.D.-J.), and through the PEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant Agreement Number 261441 PEVNET. Additional support was from a JDRF Career Development Award (5-CDA-2014-221-A-N) to S.J.R., a JDRF research grant awarded to the network of Pancreatic Organ Donors – Virus (nPOD-V) consortium (JDRF 25-2012-516); an MRC Project Grant MR/P010695/1 awarded to S.J.R. and N.G.M., a studentship grant from the Norman Family Trust (to S.J.R. and N.G.M.), a Spanish Ministry of Economy and Competiveness (SAF2017-86242-R to L.P.) and Marató TV3 (201624.10 to L.P.). L.P. is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (RYC-2013-12864) and M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) PhD fellowship.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

UMI4Cats: an R package to analyze chromatin contact profiles obtained by UMI-4C

  • Ramos-Rodríguez, Mireia
  • Subirana-Granés, Marc
  • Pasquali, Lorenzo
Motivation: UMI-4C, a technique that combines chromosome conformation capture (4C) and unique molecular identifiers (UMI), is widely used to profile and quantitatively compare targeted chromosomal contact profiles. The analysis of UMI-4C experiments presents several computational challenges, including the removal of the PCR duplication bias and the identification of differential chromatin contacts. Results: We have developed UMI4Cats (UMI-4C Analysis Turned Simple), an R package that facilitates processing, analyzing and visualizing of data obtained by UMI-4C experiments. Availability: UMI4Cats is implemented as an R package supported on Linux, MacOS and MS Windows. UMI4Cats is available from Bioconductor (https://www.bioconductor.org/packages/release/bioc/html/UMI4Cats.html) and Github (https://github.com/Pasquali-lab/UMI4Cats). Supplementary information: Supplementary data are available at Bioinformatics online., This work was supported by Spanish Ministry of Economy and Competiveness [SAF2017-86242-R], EFSD/JDRF/Lilly Programme on Type 1 Diabetes Research, ‘Unidad de Excelencia Maria de Maeztu’ [CEX2018-000792-M] and Premi Gonçal Lloveras i Vallès a l’Excelència en Investigació junior 2020.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The β-cell genomic landscape in T1D: implications for disease pathogenesis

  • Ramos-Rodríguez, Mireia
  • Pérez-González, Beatriz
  • Pasquali, Lorenzo
Purpose of review: Type 1 diabetes (T1D) develops as a consequence of a combination of genetic predisposition and environmental factors. Combined, these events trigger an autoimmune disease that results in progressive loss of pancreatic β cells, leading to insulin deficiency. This article reviews the current knowledge on the genetics of T1D with a specific focus on genetic variation in pancreatic islet regulatory networks and its implication to T1D risk and disease development. Recent findings: Accumulating evidence suggest an active role of β cells in T1D pathogenesis. Based on such observation several studies aimed in mapping T1D risk variants acting at the β cell level. Such studies unravel T1D risk loci shared with type 2 diabetes (T2D) and T1D risk variants potentially interfering with β-cell responses to external stimuli. The characterization of regulatory genomics maps of disease-relevant states and cell types can be used to elucidate the mechanistic role of β cells in the pathogenesis of T1D., This review was supported by the Spanish Ministry of Economy and Competiveness (SAF2017–86242-R), EFSD/JDRF/Lilly Programme on Type 1 Diabetes Research, Premi Gonçal Lloveras i Vallès a l’Excelència en Investigació junior 2020 and Unidad María de Maeztu (MDM-2014-0370).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes

  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Colli, Maikel Luis
  • Alvelos, Maria Inês
  • Subirana-Granés, Marc
  • Juan-Mateu, Jonàs
  • Norris, Richard
  • Turatsinze, Jean-Valery
  • Nakayasu, Ernesto S.
  • Webb-Robertson, Bobbie-Jo M.
  • Inshaw, Jamie R. J.
  • Marchetti, Piero
  • Piemonti, Lorenzo
  • Esteller, Manel
  • Todd, John A.
  • Metz, Thomas O.
  • Eizirik, Décio L.
  • Pasquali, Lorenzo
The early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic β cells. Here we show that exposure to proinflammatory cytokines reveals a marked plasticity of the β-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the β-cell transcriptome, proteome and three-dimensional chromatin structure. Our data indicate that the β-cell response to cytokines is mediated by the induction of new regulatory regions as well as the activation of primed regulatory elements prebound by islet-specific transcription factors. We find that T1D-associated loci are enriched with newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human β cells. Our study illustrates how β cells respond to a proinflammatory environment and implicate a role for stimulus response islet enhancers in T1D., L.Pasquali was supported by grants from the Spanish Ministry of Economy and Competitiveness (nos. BFU2014-58150-R and SAF2017-86242-R), Marató TV3 (no. 201624.10) and a young investigator award from the Spanish Society of Diabetes (Ayuda SED a Proyectos de Investigación, no. 2017-SED). L.Pasquali is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (no. RYC-2013-12864). The Pasquali lab is further supported by Instituto de Salud Carlos III (no. PIE16/00011). M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca PhD fellowship (no. 2019FI_B100203). J.J. was supported by a Marie Skłodowska-Curie Actions fellowship grant from the Horizons 2020 European Union (EU) Programme (project no. 660449). M.I.A. was supported by a FRIA fellowship from the Fonds de la Recherche Scientifique (FNRS) (no. 26410496). Human islets were provided through the European Consortium for Islet Transplantation distribution program for basic research supported by JDRF (no. 31-2008-416). D.L.E. was supported by the Walloon Region through the FRFS-WELBIO Fund for Strategic Fundamental research (no. CR-2015A-06s and CR-2019C-04) and by grants from the Fonds National de la Recherche Scientifique (no. T003613F), the Horizon 2020 Programme (project T2Dsystems, no. GA667191), Brussels Capital Region Innoviris (project DiaType, no. 2017-PFS-24), Dutch Diabetes Research Fundation (project Innovate2CureType1, DDRF; no. 2018.10.002) and the Innovative Medicines Initiative 2 Joint Undertaking (project INNODIA, no. 115797). This Innovative Medicines Initiative 2 Joint Undertaking receives support from the EU’s Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations, JDRF and the Leona M. and Harry B. Helmsley Charitable Trust (project INNODIA, no. 115797). T.O.M. and D.L.E. were supported by a grant from the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases-Human Islet Research Network Consortium (no. 1UC4DK104166-01). Part of the work was performed at the Environmental Molecular Sciences Laboratory, a US Department of Energy national scientific user facility located at Pacific Northwest National Laboratory. Battelle operates the Pacific Northwest National Laboratory for the Department of Energy (contract no. DE-AC05-76RLO01830).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation

  • Bueno-Costa, Alberto
  • Piñeyro, David
  • Soler, Marta
  • Javierre, Biola M.
  • Raurell Vila, Helena
  • Subirana-Granés, Marc
  • Pasquali, Lorenzo
  • Martinez-Climent, Jose A.
  • Esteller, Manel
This work was supported by the Health Department PERIS-project no. SLT/002/16/00374 and AGAUR-projects no. 2017SGR1080, 2014SGR633, 2017SGR1033, and 2009SGR1315 of the Catalan Government (Generalitat de Catalunya); the Spanish Institute of Health Carlos III (ISCIII) project no. DTS16/00153, and CIBERONC CB16/12/00312 and CB16/12/00489; and Ministerio de Economía y Competitividad (MINECO) project nos. SAF2014-55000-R, BFU2014-57466-P, SAF2017-89673-R, SAF2017-86242-R, and SAF2015-70270-REDT cofinanced by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF; the Cellex Foundation; and “la Caixa” Bank Foundation (LCF/PR/GN18/51140001). We thank Dr Thomas Graf for providing the transdifferentiation model.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell, Helena
  • Munté, Elisabeth
  • Soto, José Luis
  • Alonso Sánchez, Ángel Miguel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel Luis
  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Pasquali, Lorenzo
  • Eizirik, Décio L.
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells., This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS), Welbio CR-2015A-06 and CR-2019C-04, Belgium; the Horizon 2020 Program, T2Dsystems (GA667191); the National Institutes of Health, NIH-NIDDK-HIRN Consortium 1UC4DK104166-01 and Innovate2CureType1 - Dutch Diabetes Research Fundation (DDRF). D.L.E. and P.M. have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No. 115797 (INNODIA). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”. The DiViD study is funded by The South-Eastern Norway Regional Health Authority (grant to K.D.-J.), the Novo Nordisk Foundation (grant to K.D.-J.), and through the PEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant Agreement Number 261441 PEVNET. Additional support was from a JDRF Career Development Award (5-CDA-2014-221-A-N) to S.J.R., a JDRF research grant awarded to the network of Pancreatic Organ Donors – Virus (nPOD-V) consortium (JDRF 25-2012-516); an MRC Project Grant MR/P010695/1 awarded to S.J.R. and N.G.M., a studentship grant from the Norman Family Trust (to S.J.R. and N.G.M.), a Spanish Ministry of Economy and Competiveness (SAF2017-86242-R to L.P.) and Marató TV3 (201624.10 to L.P.). L.P. is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (RYC-2013-12864) and M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) PhD fellowship.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

UMI4Cats: an R package to analyze chromatin contact profiles obtained by UMI-4C

  • Ramos-Rodríguez, Mireia
  • Subirana-Granés, Marc
  • Pasquali, Lorenzo
Motivation: UMI-4C, a technique that combines chromosome conformation capture (4C) and unique molecular identifiers (UMI), is widely used to profile and quantitatively compare targeted chromosomal contact profiles. The analysis of UMI-4C experiments presents several computational challenges, including the removal of the PCR duplication bias and the identification of differential chromatin contacts. Results: We have developed UMI4Cats (UMI-4C Analysis Turned Simple), an R package that facilitates processing, analyzing and visualizing of data obtained by UMI-4C experiments. Availability: UMI4Cats is implemented as an R package supported on Linux, MacOS and MS Windows. UMI4Cats is available from Bioconductor (https://www.bioconductor.org/packages/release/bioc/html/UMI4Cats.html) and Github (https://github.com/Pasquali-lab/UMI4Cats). Supplementary information: Supplementary data are available at Bioinformatics online., This work was supported by Spanish Ministry of Economy and Competiveness [SAF2017-86242-R], EFSD/JDRF/Lilly Programme on Type 1 Diabetes Research, ‘Unidad de Excelencia Maria de Maeztu’ [CEX2018-000792-M] and Premi Gonçal Lloveras i Vallès a l’Excelència en Investigació junior 2020.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Implications of noncoding regulatory functions in the development of insulinomas

  • Ramos-Rodríguez, Mireia
  • Subirana-Granés, Marc
  • Norris, Richard
  • Fernández Ruiz, Ángel
  • Fuentes Páez, Georgina
  • Pérez-González, Beatriz
  • Berenguer Balaguer, Clara
  • Raurell Vila, Helena
  • López Bigas, Núria
  • González-Pérez, Abel
  • Pasquali, Lorenzo
Insulinomas are rare neuroendocrine tumors arising from pancreatic β cells, characterized by aberrant proliferation and altered insulin secretion, leading to glucose homeostasis failure. With the aim of uncovering the role of noncoding regulatory regions and their aberrations in the development of these tumors, we coupled epigenetic and transcriptome profiling with whole-genome sequencing. As a result, we unraveled somatic mutations associated with changes in regulatory functions. Critically, these regions impact insulin secretion, tumor development, and epigenetic modifying genes, including polycomb complex components. Chromatin remodeling is apparent in insulinoma-selective domains shared across patients, containing a specific set of regulatory sequences dominated by the SOX17 binding motif. Moreover, many of these regions are H3K27me3 repressed in β cells, suggesting that tumoral transition involves derepression of polycomb-targeted domains. Our work provides a compendium of aberrant cis-regulatory elements affecting the function and fate of β cells in their progression to insulinomas and a framework to identify coding and noncoding driver mutations., This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2017-86242-R and PID2020-117099RB-I00) “Unidad de Excelencia Maria de Maeztu” (CEX2018-000792-M). M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award. MARBiobanc’s work was supported by grants from Instituto de Salud Carlos III/FEDER (PT20/00023) and the “Xarxa de Bancs de tumors” sponsored by Pla Director d'Oncologia de Catalunya (XBTC). The islet isolation has been funded by grants PI19/00246 and PI22/00334 to E.M. from Instituto de Salud Carlos III, cofinanced by the European Regional Development Fund (ERCF).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation

  • Bueno-Costa, Alberto
  • Piñeyro, David
  • Soler, Marta
  • Javierre, Biola M.
  • Raurell Vila, Helena
  • Subirana-Granés, Marc
  • Pasquali, Lorenzo
  • Martinez-Climent, Jose A.
  • Esteller, Manel
This work was supported by the Health Department PERIS-project no. SLT/002/16/00374 and AGAUR-projects no. 2017SGR1080, 2014SGR633, 2017SGR1033, and 2009SGR1315 of the Catalan Government (Generalitat de Catalunya); the Spanish Institute of Health Carlos III (ISCIII) project no. DTS16/00153, and CIBERONC CB16/12/00312 and CB16/12/00489; and Ministerio de Economía y Competitividad (MINECO) project nos. SAF2014-55000-R, BFU2014-57466-P, SAF2017-89673-R, SAF2017-86242-R, and SAF2015-70270-REDT cofinanced by the European Development Regional Fund, ‘A way to achieve Europe’ ERDF; the Cellex Foundation; and “la Caixa” Bank Foundation (LCF/PR/GN18/51140001). We thank Dr Thomas Graf for providing the transdifferentiation model.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes

  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Colli, Maikel Luis
  • Alvelos, Maria Inês
  • Subirana-Granés, Marc
  • Juan-Mateu, Jonàs
  • Norris, Richard
  • Turatsinze, Jean-Valery
  • Nakayasu, Ernesto S.
  • Webb-Robertson, Bobbie-Jo M.
  • Inshaw, Jamie R. J.
  • Marchetti, Piero
  • Piemonti, Lorenzo
  • Esteller, Manel
  • Todd, John A.
  • Metz, Thomas O.
  • Eizirik, Décio L.
  • Pasquali, Lorenzo
The early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic β cells. Here we show that exposure to proinflammatory cytokines reveals a marked plasticity of the β-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the β-cell transcriptome, proteome and three-dimensional chromatin structure. Our data indicate that the β-cell response to cytokines is mediated by the induction of new regulatory regions as well as the activation of primed regulatory elements prebound by islet-specific transcription factors. We find that T1D-associated loci are enriched with newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human β cells. Our study illustrates how β cells respond to a proinflammatory environment and implicate a role for stimulus response islet enhancers in T1D., L.Pasquali was supported by grants from the Spanish Ministry of Economy and Competitiveness (nos. BFU2014-58150-R and SAF2017-86242-R), Marató TV3 (no. 201624.10) and a young investigator award from the Spanish Society of Diabetes (Ayuda SED a Proyectos de Investigación, no. 2017-SED). L.Pasquali is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (no. RYC-2013-12864). The Pasquali lab is further supported by Instituto de Salud Carlos III (no. PIE16/00011). M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca PhD fellowship (no. 2019FI_B100203). J.J. was supported by a Marie Skłodowska-Curie Actions fellowship grant from the Horizons 2020 European Union (EU) Programme (project no. 660449). M.I.A. was supported by a FRIA fellowship from the Fonds de la Recherche Scientifique (FNRS) (no. 26410496). Human islets were provided through the European Consortium for Islet Transplantation distribution program for basic research supported by JDRF (no. 31-2008-416). D.L.E. was supported by the Walloon Region through the FRFS-WELBIO Fund for Strategic Fundamental research (no. CR-2015A-06s and CR-2019C-04) and by grants from the Fonds National de la Recherche Scientifique (no. T003613F), the Horizon 2020 Programme (project T2Dsystems, no. GA667191), Brussels Capital Region Innoviris (project DiaType, no. 2017-PFS-24), Dutch Diabetes Research Fundation (project Innovate2CureType1, DDRF; no. 2018.10.002) and the Innovative Medicines Initiative 2 Joint Undertaking (project INNODIA, no. 115797). This Innovative Medicines Initiative 2 Joint Undertaking receives support from the EU’s Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations, JDRF and the Leona M. and Harry B. Helmsley Charitable Trust (project INNODIA, no. 115797). T.O.M. and D.L.E. were supported by a grant from the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases-Human Islet Research Network Consortium (no. 1UC4DK104166-01). Part of the work was performed at the Environmental Molecular Sciences Laboratory, a US Department of Energy national scientific user facility located at Pacific Northwest National Laboratory. Battelle operates the Pacific Northwest National Laboratory for the Department of Energy (contract no. DE-AC05-76RLO01830).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Altered chromatin landscape and 3D interactions associated with primary constitutional MLH1 epimutations

  • Climent-Cantó, Paula
  • Subirana-Granés, Marc
  • Ramos-Rodríguez, Mireia
  • Dámaso, Estela
  • Marín, Fátima
  • Vara, Covadonga
  • Pérez-González, Beatriz
  • Raurell Vila, Helena
  • Munté, Elisabet
  • Soto, José Luis
  • Alonso, Ángel
  • Shin, GiWon
  • Ji, Hanlee
  • Hitchins, Megan
  • Capellá, Gabriel
  • Pasquali, Lorenzo
  • Pineda, Marta
Background: Lynch syndrome (LS), characterised by an increased risk for cancer, is mainly caused by germline pathogenic variants affecting a mismatch repair gene (MLH1, MSH2, MSH6, PMS2). Occasionally, LS may be caused by constitutional MLH1 epimutation (CME) characterised by soma-wide methylation of one allele of the MLH1 promoter. Most of these are "primary" epimutations, arising de novo without any apparent underlying cis-genetic cause, and are reversible between generations. We aimed to characterise genetic and gene regulatory changes associated with primary CME to elucidate possible underlying molecular mechanisms. Methods: Four carriers of a primary CME and three non-methylated relatives carrying the same genetic haplotype were included. Genetic alterations were sought using linked-read WGS in blood DNA. Transcriptome (RNA-seq), chromatin landscape (ATAC-seq, H3K27ac CUT&Tag) and 3D chromatin interactions (UMI-4C) were studied in lymphoblastoid cell lines. The MLH1 promoter SNP (c.-93G > A, rs1800734) was used as a reporter in heterozygotes to assess allele-specific chromatin conformation states. Results: MLH1 epimutant alleles presented a closed chromatin conformation and decreased levels of H3K27ac, as compared to the unmethylated allele. Moreover, the epimutant MLH1 promoter exhibited differential 3D chromatin contacts, including lost and gained interactions with distal regulatory elements. Of note, rare genetic alterations potentially affecting transcription factor binding sites were found in the promoter-contacting region of CME carriers. Conclusions: Primary CMEs present allele-specific differential interaction patterns with neighbouring genes and regulatory elements. The role of the identified cis-regulatory regions in the molecular mechanism underlying the origin and maintenance of CME requires further investigation., This study was supported by the National Institute of Health/National Cancer Institute (R01CA218342), the Spanish Ministry of Science and Innovation, which is part of Agencia Estatal de Investigación (AEI), through the Retos Investigación grants (SAF2015-68016-R, PID2019-111254RB-I00, PID2020-117099RB-I00, PID2023-151585OB-I00, and SAF2017-86242-R), CIBERONC (CB16/12/00234), and the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya grant to support the activities of research groups (2021 SGR 01112). We also thank the CERCA Program/Generalitat de Catalunya for institutional support. M.R.-R. is supported by the IMPULSO Talento Joven grant from DiabetesCERO and the EFSD/Lilly Young Investigator Award.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The β-cell genomic landscape in T1D: implications for disease pathogenesis

  • Ramos-Rodríguez, Mireia
  • Pérez-González, Beatriz
  • Pasquali, Lorenzo
Purpose of review: Type 1 diabetes (T1D) develops as a consequence of a combination of genetic predisposition and environmental factors. Combined, these events trigger an autoimmune disease that results in progressive loss of pancreatic β cells, leading to insulin deficiency. This article reviews the current knowledge on the genetics of T1D with a specific focus on genetic variation in pancreatic islet regulatory networks and its implication to T1D risk and disease development. Recent findings: Accumulating evidence suggest an active role of β cells in T1D pathogenesis. Based on such observation several studies aimed in mapping T1D risk variants acting at the β cell level. Such studies unravel T1D risk loci shared with type 2 diabetes (T2D) and T1D risk variants potentially interfering with β-cell responses to external stimuli. The characterization of regulatory genomics maps of disease-relevant states and cell types can be used to elucidate the mechanistic role of β cells in the pathogenesis of T1D., This review was supported by the Spanish Ministry of Economy and Competiveness (SAF2017–86242-R), EFSD/JDRF/Lilly Programme on Type 1 Diabetes Research, Premi Gonçal Lloveras i Vallès a l’Excelència en Investigació junior 2020 and Unidad María de Maeztu (MDM-2014-0370).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel L.|||0000-0002-2200-4761
  • Ramos Rodríguez, Mireia|||0000-0001-8083-2445
  • Nakayasu, Ernesto S.|||0000-0002-4056-2695
  • Alvelos, Maria I.
  • Lopes, Miguel
  • Hill, Jessica L. E.
  • Turatsinze, Jean-Valery|||0000-0001-9492-6274
  • Coomans de Brachène, Alexandra
  • Russell, Mark A.
  • Raurell Vila, Helena|||0000-0003-1196-836X
  • Castela, Angela
  • Juan-Mateu, Jonàs
  • Webb-Robertson, Bobbie-Jo M.
  • Krogvold, Lars
  • Dahl-Jorgensen, Knut
  • Marselli, Lorella|||0000-0002-6698-2962
  • Marchetti, Piero
  • Richardson, Sarah J.|||0000-0002-1160-6062
  • Morgan, Noel G.|||0000-0003-1537-8113
  • Metz, Thomas O.|||0000-0001-6049-3968
  • Pasquali, Lorenzo|||0000-0003-2423-1826
  • Eizirik, Décio L.|||0000-0003-2453-5889
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Implications of noncoding regulatory functions in the development of insulinomas

  • Ramos-Rodríguez, Mireia
  • Subirana Granés, Marc
  • Norris, Richard|||0000-0001-8446-5507
  • Sordi, Valeria
  • Fernández, Esteve|||0000-0003-4239-723X
  • Fuentes-Páez, Georgina
  • Pérez-González, Beatriz|||0000-0001-9849-5176
  • Berenguer Balaguer, Clara
  • Raurell-Vila, Helena
  • Chowdhury, Murad
  • Corripio, Raquel|||0000-0003-3344-8269
  • Partelli, Stefano
  • López-Bigas, Núria
  • Pellegrini, Silvia
  • Montanya, Eduard|||0000-0003-2518-9076
  • Nacher Garcia, Montserrat|||0000-0002-8458-9275
  • Falconi, Massimo
  • Layer, R.
  • Rovira, Meritxell|||0000-0002-0538-4846
  • González-Pérez, A.
  • Piemonti, Lorenzo|||0000-0002-2172-2198
  • Pasquali, Lorenzo|||0000-0003-2423-1826
Insulinomas are rare neuroendocrine tumors arising from pancreatic β cells, characterized by aberrant proliferation and altered insulin secretion, leading to glucose homeostasis failure. With the aim of uncovering the role of noncoding regulatory regions and their aberrations in the development of these tumors, we coupled epigenetic and transcriptome profiling with whole-genome sequencing. As a result, we unraveled somatic mutations associated with changes in regulatory functions. Critically, these regions impact insulin secretion, tumor development, and epigenetic modifying genes, including polycomb complex components. Chromatin remodeling is apparent in insulinoma-selective domains shared across patients, containing a specific set of regulatory sequences dominated by the SOX17 binding motif. Moreover, many of these regions are H3K27me3 repressed in β cells, suggesting that tumoral transition involves derepression of polycomb-targeted domains. Our work provides a compendium of aberrant cis-regulatory elements affecting the function and fate of β cells in their progression to insulinomas and a framework to identify coding and noncoding driver mutations.